Jun 04, 2020
Duchesnay USA and FabOverFifty launch Straight Talk: Sex and the Menopausal Woman video
May 19, 2020
Duchesnay USA and Plushcare announce a new partnership to facilitate access to healthcare for menopausal women through telemedicine
Oct 18, 2019
Survey Reveals that Menopausal Women Prefer Oral Medication Over Topical Options to Treat Vaginal Dryness
Aug 20, 2019
Duchesnay USA launches three videos featuring gynecologist and menopause care specialist, Dr. Barb DePree
Aug 13, 2019
Duchesnay USA announces the launch of a new Osphena® (ospemifene) website
Jan 29, 2019
Duchesnay Inc. Receives Approval of Supplemental New Drug Application (sNDA) to Add Moderate to Severe Vaginal Dryness, a Symptom of Vulvar and Vaginal Atrophy (VVA) Due to Menopause, to the Indication of Osphena® (ospemifene)
Oct 29, 2018
Duchesnay USA, Maker of Osphena®, Applauds Expanded Coverage for Treatments for Dyspareunia due to Menopause under Medicare Part D
Oct 23, 2018
Duchesnay Inc. Announces Submission of Supplemental New Drug Application (sNDA) for Osphena® (ospemifene) to U.S. FDA Seeking Approval for the Treatment of Vaginal Dryness, a Symptom of Vulvar and Vaginal Atrophy (VVA) Due to Menopause
Sep 14, 2018
Duchesnay Inc. to Present a Poster on Adherence, Persistence and Healthcare Costs Associated with Ospemifene at 2018 Annual Meeting of the North American Menopause Society (NAMS)
Sep 13, 2018
Duchesnay Inc. to Present a Poster on Ospemifene at the 2018 Annual Meeting of the North American Menopause Society (NAMS)
Sep 12, 2018
Duchesnay Inc. to Present a Poster on the Efficacy and Safety of Ospemifene in Menopausal Women with Moderate to Severe Vaginal Dryness at 2018 Annual Meeting of the North American Menopause Society (NAMS)
Apr 25, 2018
Duchesnay, Inc. Announces Presentation of Abstract at 16th World Congress on Menopause